Over-the-Counter Monograph Drug User Fee Amendments

Hozzl · 2025-10-07T18:55:04Z

Explore the details of Senate Bill 2292 Over-the-Counter Monograph Drug User Fee Amendments currently in Congress. Get insights into its purpose, current status, sponsors, and potential impact on Health. Stay informed on legislative developments.

10/7/2025, 6:55 PM

Summary of Bill S 2292

The bill introduced in the 119th Congress, designated as S. 2292, aims to amend the Federal Food, Drug, and Cosmetic Act to modify and prolong the user fee initiative concerning over-the-counter monograph drugs.

Read the Full Bill

Formatted Text PDF Formatted XML

Current Status of Bill S 2292

Bill S 2292 is currently in the status of Bill Introduced since July 15, 2025. Bill S 2292 was introduced during Congress 119 and was introduced to the Senate on July 15, 2025. Bill S 2292's most recent activity was Placed on Senate Legislative Calendar under General Orders. Calendar No. 152. as of September 8, 2025

Bipartisan Support of Bill S 2292

Total Number of Sponsors

Democrat Sponsors

Republican Sponsors

Unaffiliated Sponsors

Total Number of Cosponsors

Democrat Cosponsors

Republican Cosponsors

Unaffiliated Cosponsors

Policy Area and Potential Impact of Bill S 2292

Primary Policy Focus

Health

Potential Impact Areas

- Congressional oversight

- Drug safety, medical device, and laboratory regulation

- User charges and fees

Alternate Title(s) of Bill S 2292

A bill to amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user fee program for over-the-counter monograph drugs, and for other purposes.

Comments

Coraline Buckley

25,789

3 months ago

I think this bill is good for us. It will help make things better for everyone. I support it because it will make things easier for me and others.

Jalen Ford

26,008

3 months ago

I'm really excited about this bill! It will help make over-the-counter drugs more accessible and affordable for everyone. Can't wait to see the positive impact it has on healthcare in our country. #S2292 #OTCdrugs #healthcarewin